PDMR Dealings

RNS Number : 6151L

Accrol Group Holdings PLC

14 January 2021

 

14 January 2021

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Accrol Group Holdings plc

(the "Company")

AIM: ACRL

PDMR Dealings

Accrol Group Holdings plc, a leading independent tissue converter in the UK, announces that as a result of the Company releasing its half-year results for the six months ended 31 October 2020, certain shares held by PDMRs have ceased to be locked in and as a result the following PDMR dealings have occurred.

PDMR	Number of ordinary shares held pre dealing	Number of ordinary shares sold	Number of ordinary shares held post dealing	% of issued share capital held post dealing
Gareth Jenkins	5,598,632	1,333,000	4,265,632	1.37%
Mark Dewhurst	1,489,975	444,000	1,045,975	0.34%
Graham Cox	683,970	333,000	350,970	0.11%

Further details of the PDMR dealings are included below.

For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman	Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer
Zeus Capital Limited (Nominated Adviser & Broker)
Dan Bate / Jordan Warburton	Tel: [phone]
Dominic King / John Goold	Tel: [phone]
Liberum Capital Limited (Joint Broker)	Tel: [phone]
Clayton Bush / Edward Thomas
Belvedere Communications Limited
Cat Valentine	Tel: [phone]
Keeley Clarke	Tel: [phone]
Llew Angus	Tel:  [phone]
	[e-mail]

Overview of Accrol

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisition of a state-of-the-art tissue converter based in Leicester, the Group now operates from five sites, including four in Lancashire, which generate revenues totalling c.16% of the £1.7bn UK retail tissue market.

For more information, please visit www.accrol.com .

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Gareth Jenkins
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Accrol Group Holdings plc
b)	LEI	213800MC56M5G69RJ226
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of £0.001 each ISIN: GB00BZ6VT592
b)	Nature of the transaction	Sale of shares
c)	Price(s) and volume(s)	Price: £0.705 Volume: 1,333,000
d)	Aggregated information - Aggregated volume - Price	Price: £0.705 Volume: 1,333,000
e)	Date of the transaction	13 January 2021
f)	Place of the transaction	London Stock Exchange, AIM

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mark Dewhurst
2	Reason for the notification
a)	Position/status	Chief Operating Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Accrol Group Holdings plc
b)	LEI	213800MC56M5G69RJ226
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of £0.001 each ISIN: GB00BZ6VT592
b)	Nature of the transaction	Sale of shares
c)	Price(s) and volume(s)	Price: £0.705 Volume: 444,000
d)	Aggregated information - Aggregated volume - Price	Price: £0.705 Volume: 444,000
e)	Date of the transaction	13 January 2021
f)	Place of the transaction	London Stock Exchange, AIM

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Graham Cox
2	Reason for the notification
a)	Position/status	Commercial Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Accrol Group Holdings plc
b)	LEI	213800MC56M5G69RJ226
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of £0.001 each ISIN: GB00BZ6VT592
b)	Nature of the transaction	Sale of shares
c)	Price(s) and volume(s)	Price: £0.705 Volume: 333,000
d)	Aggregated information - Aggregated volume - Price	Price: £0.705 Volume: 333,000
e)	Date of the transaction	13 January 2021
f)	Place of the transaction	London Stock Exchange, AIM

 

END

 

 

DSHUOSBRARUAAAR